Verifarma International, S.L.

Based in Spain, Verifarma specializes in technological solutions for the pharmaceutical and life sciences industries, focusing on quality management, serialization, and medication traceability. Verifarma International, S. L. was founded in 2007 in Las Palmas, Spain, providing solutions for the pharmaceutical sector.

The company has completed one significant deal, with the most recent investment occurring on March 30, 2026, when MTIP invested in the firm, although financial terms were not disclosed. Verifarma specializes in providing comprehensive technological solutions tailored to the pharmaceutical and life sciences industries, focusing on quality management, serialization, and traceability of medications. The company's primary offerings include Verifarma Track & Trace, which enables pharmaceutical laboratories and supply chain stakeholders to meet international regulations for drug serialization and traceability, ensuring compliance with standards such as the EU FMD. Additionally, Verifarma Integrated Solutions encompasses Quality Management Systems (QMS), Laboratory Information Management Systems (LIMS), Regulatory Information Management Systems (RIMS), and pharmacovigilance tools, all designed to centralize processes and enhance operational efficiency.

These solutions are implemented in over 27 countries, catering to a diverse clientele that includes more than 2,000 companies, such as laboratories, distributors, and pharmacies. Verifarma's products are utilized across various international markets, providing critical support in regions with stringent regulatory requirements. Verifarma's revenue is generated through a business model that emphasizes B2B transactions, specifically selling to pharmaceutical companies and life sciences organizations. Clients typically engage with Verifarma through subscription-based contracts for its various software solutions, which can include multiple modules for quality and regulatory management.

The company's flagship products, such as Verifarma Track & Trace and Integrated Solutions, are offered under customizable pricing plans, allowing clients to select services that align with their specific operational needs. Revenue transactions are structured around annual or multi-year agreements, facilitating ongoing support and software updates. This structured engagement ensures that clients benefit from continuous improvements and compliance with evolving regulatory landscapes, thereby enhancing their operational capabilities in the highly regulated pharmaceutical sector. Verifarma International, S.

L. plans to leverage its recent investment from MTIP in March 2026 to accelerate its growth. The company is actively designing and preparing to launch new products targeted for the pharmaceutical market. Furthermore, Verifarma aims to expand into new geographic regions, enhancing its presence in markets with increasing demands for regulatory compliance solutions.

Specific timelines and targeted markets for these expansions will be outlined as development progresses.